UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 179 filers reported holding UNIQURE NV in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $28,806 | -44.2% | 6,430 | -35.2% | 0.00% | -42.9% |
| Q1 2024 | $51,594 | +21.8% | 9,922 | +58.5% | 0.01% | -12.5% |
| Q4 2023 | $42,367 | +225.0% | 6,258 | +222.1% | 0.01% | +100.0% |
| Q3 2023 | $13,038 | -94.0% | 1,943 | -89.8% | 0.00% | -94.0% |
| Q2 2023 | $218,428 | -43.1% | 19,060 | -0.1% | 0.07% | -48.5% |
| Q1 2023 | $384,130 | -87.3% | 19,073 | -85.7% | 0.13% | -89.3% |
| Q4 2022 | $3,014,657 | +37583.2% | 132,980 | +30330.2% | 1.21% | +40300.0% |
| Q3 2022 | $8,000 | – | 437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 939,966 | $21,309,029 | 5.53% |
| Aquilo Capital Management, LLC | 624,854 | $14,165,440 | 5.32% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 631,500 | $14,297,160 | 4.42% |
| Nantahala Capital Management | 2,700,239 | $61,214,418 | 3.97% |
| Integral Health Asset Management, LLC | 550,000 | $12,468,500 | 2.62% |
| Privium Fund Management B.V. | 301,298 | $6,830,426 | 2.59% |
| 683 Capital Management, LLC | 1,145,000 | $25,957,150 | 2.20% |
| PFM Health Sciences, LP | 2,302,314 | $52,193,458 | 1.87% |
| Nantahala Capital Management | 1,187,700 | $26,925,159 | 1.74% |
| Jetstream Capital LLC | 30,000 | $680,100 | 1.44% |